- Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma - (NICE technology appraisal guidance [TA269])
Published 2012 (National Institute for Health and Care Excellence)
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Published 2015 (American College of Medical Genetics and Genomics) (National Society of Genetic Counselors)
domingo, 9 de abril de 2017
MELANOMA - https://phgkb.cdc.gov/GAPPKB/phgHome.do - MELANOMA
From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.